Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Treating chronic constipation : How should we interpret the recommendations?

David A Johnson1

  • 1Department of Gastroenterology, Eastern VA Medical School, Norfolk, Virginia 23502, USA. dajevms@aol.com

Clinical Drug Investigation
|December 14, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dietary Intake of Micro- and Nanoplastics: Potential Adverse GI Effects on Microbiome, Inflammation, and Neoplasia.

Microorganisms·2026
Same author

A Comprehensive Narrative Review of Potential Gastrointestinal Adverse Effects From Micro(nano) Plastic Exposure.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association·2025
Same author

Oral microbiome and inflammatory bowel disease: New understanding and call to action.

World journal of gastroenterology·2025
Same author

Whole RNA-Seq Analysis Reveals Longitudinal Proteostasis Network Responses to Photoreceptor Outer Segment Trafficking and Degradation in RPE Cells.

Cells·2025
Same author

Plastics: Here, There, and Everywhere: Implications for Gastrointestinal Health and Disease.

The American journal of gastroenterology·2025
Same author

Reducing Falls in Hospitalized Children and Adolescents with Cancer and Blood Disorders: A Quality Improvement Journey.

Pediatric quality & safety·2024
Same journal

Desvenlafaxine as a Potential First-Line Treatment for Major Depressive Disorder: A Comprehensive Review and Consensus-Based Clinical Perspective on Efficacy, Safety and Patient Selection Profiles.

Clinical drug investigation·2026
Same journal

Effectiveness of the Approved Nirmatrelvir/Ritonavir and Molnupiravir Regimens for Treatment of Mild/Moderate Laboratory-Confirmed SARS-CoV-2 Infection in Patients Aged 18-64 Years in Hong Kong: A Population-Based Cohort Study.

Clinical drug investigation·2026
Same journal

Assessing the Adverse Events of Roflumilast and Tapinarof Use in Pediatric and Young Adult Patients with Atopic Dermatitis: A Systematic Review.

Clinical drug investigation·2026
Same journal

Repurposing Antipsychotics in Cancer Therapy: Modulation of Autophagy Mechanisms.

Clinical drug investigation·2026
Same journal

Deuruxolitinib: New Approval.

Clinical drug investigation·2026
Same journal

Efficacy, Safety, Quality of Life, and Adherence of Dupilumab in Pediatric Atopic Dermatitis: A Systematic Review.

Clinical drug investigation·2026
See all related articles

New guidelines help clinicians manage chronic constipation, a gastrointestinal motility disorder. For persistent cases, consider osmotic laxatives, tegaserod, or lubiprostone for better symptom relief and safety.

Area of Science:

  • Gastroenterology
  • Pharmacology
  • Clinical Practice Guidelines

Background:

  • Chronic constipation is a prevalent gastrointestinal motility disorder significantly impacting patient quality of life.
  • Recent publications have introduced updated recommendations for the diagnosis and treatment of chronic constipation.
  • Existing interventions like lifestyle changes and bulking agents show limited efficacy for chronic constipation.

Purpose of the Study:

  • To guide clinicians in implementing new diagnostic and treatment recommendations for chronic constipation.
  • To review the evidence supporting various pharmacological agents for chronic constipation management.
  • To highlight advancements in defining and treating chronic constipation.

Main Methods:

  • Literature review of recent clinical practice guidelines and pharmacological studies.

Related Experiment Videos

  • Analysis of efficacy and safety data for different classes of laxatives and pro-motility agents.
  • Synthesis of evidence to support clinical decision-making in chronic constipation.

    • Main Results:

    • Lifestyle interventions and bulking agents have insufficient evidence for chronic constipation.
    • Osmotic laxatives increase stool frequency but have adverse effects and limited symptom relief.
    • Serotonin (5-HT4) receptor agonists (tegaserod) and chloride channel activators (lubiprostone) demonstrate high-quality evidence and acceptable safety profiles.

    Conclusions:

    • Recent advances refine the definition and pharmacological management of chronic constipation.
    • Tegaserod and lubiprostone represent effective treatment options with favorable safety profiles.
    • Clinicians can utilize updated recommendations to select appropriate medical regimens for patients with chronic constipation.